Studies of Interactions Among Normal and Abnormal Blood Cells, and the Vessel Wall, and Studies of Genetic and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell and Coagulation Disorders

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Blood contains red blood cells, white blood cells, and platelets, as well as a fluid portion termed plasma. We primarily study blood platelets, but sometimes we also analyze the blood of patients with red blood cell disorders (such as sickle cell disease), white blood cell disorders, and disorders of the blood clotting factors found in plasma. Blood platelets are small cell fragments that help people stop bleeding after blood vessels are damaged. Some individuals have abnormalities in their blood platelets that result in them not functioning properly. One such disorder is Glanzmann thrombasthenia. Most such patients have a bleeding disorder characterized by nosebleeds, gum bleeding, easy bruising (black and blue marks), heavy menstrual periods in women, and excessive bleeding after surgery or trauma. Our laboratory performs advanced tests of platelet function and platelet biochemistry. If we find evidence that a genetic disorder may be responsible, we analyze the genetic material (DNA and RNA) from the volunteer, and when possible, close family members to identify the precise defect.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: t
View:

⁃ A. Normal Healthy Volunteers:

• Normal healthy volunteers

• 18 years of age or older

• Either sex

• Any ethnic background.

⁃ B. Patients with Glanzmann thrombasthenia or their relatives, inherited qualitative and/or quantitative platelet disorders, inherited disorders of white blood cells, inherited disorders of coagulation (including von Willebrand disease):

• Adults and children

• Either sex

• Any ethnic background

Locations
United States
New York
Rockefeller University Hospital
RECRUITING
New York
Contact Information
Primary
Recruitment Specialist
rucares@rockefeller.edu
1-800-782-2737
Time Frame
Start Date: 2005-09
Estimated Completion Date: 2030-06
Participants
Target number of participants: 60
Treatments
Normal
Normal, healthy volunteers 18 years of age or older of either sex and any ethnic background
Glanzmann thrombasthenia
Patients with Glanzmann thrombasthenia or their relatives, inherited qualitative and/or quantitative platelet disorders, inherited disorders of white blood cells, inherited disorders of coagulation
Sponsors
Leads: Rockefeller University
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)

This content was sourced from clinicaltrials.gov